Physician profile
Devon Conway
NPI 1699310870
$2,121.52
in general payments reported to CMS, 2019-2025
15 companies · $922 in 2025
The $922 reported for 2025 was more than what 82% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,200 · 2025: $922.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $922.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $921.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gotham Surgical Solutions & Devices, INC. | $1,200.00 | 2021 | |
| Abbvie INC. | $238.31 | 2025 | |
| Leo Pharma INC. | $160.49 | 2025 | Adbry, Anzupgo |
| Sun Pharmaceutical Industries INC. | $138.92 | 2025 | |
| Novartis Pharmaceuticals Corporation | $112.32 | 2025 | |
| Incyte Corporation | $70.94 | 2025 | Opzelura |
| Pfizer INC. | $29.27 | 2025 | |
| Verrica Pharmaceuticals INC. | $25.18 | 2025 | Ycanth |
| Organon LLC | $24.55 | 2025 | |
| Genzyme Corporation | $23.08 | 2025 | |
| Galderma Laboratories, L.P. | $22.32 | 2025 | Nemluvio |
| Arcutis Biotherapeutics, INC. | $21.55 | 2025 | Zoryve |
| Lilly USA, LLC | $20.30 | 2025 | Taltz, Ebglyss |
| Strata Skin Sciences, INC. | $19.38 | 2025 | Xtrac |
| Mayne Pharma Commercial LLC | $14.91 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Devon Conway listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.